Skip to content
healthcare.dev
Get a free key

Besponsa

NDC 0008-0100, inotuzumab ozogamicin, injection, powder, lyophilized, for solution, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

Product NDC
0008-0100
Status
Listed
Labeler
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761040
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0008-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INOTUZUMAB OZOGAMICIN.25 mg/mL

Pharmacologic classes

CD22-directed Antibody Interactions [MoA]; CD22-directed Immunoconjugate [EPC]; Decreased DNA Integrity [PE]; Immunoconjugates [CS]; Increased Cellular Death [PE]

Package NDCNDC-11Package
0008-0100-01000080100011 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cc7014b1-c775-411d-b374-8113248b4077

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0008-0100

Use it

Look up 0008-0100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0008-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0008-0100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.